Πέμπτη 18 Αυγούστου 2016

Gene Expression Classifier Testing and the Surgical Decision-Making Process for Patients With Thyroid Nodules—Reply

olr160004.pdf.gif

In Reply Drs Kloos and Barth, employees and equity owners of Veracyte raise questions about the design and findings of our study examining the effect of Veracyte's Afirma gene expression classifier (GEC) on the practice of 10 thyroid surgeons at an academic institution.

from #ORL via xlomafota13 on Inoreader http://ift.tt/2biENOs
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου